Skip to main content

Table 2 GP attitudes to antibiotic prescribing at baseline and follow-up by intervention group

From: Evaluation of a web-based intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial

 

CRP group (n=73)

Communication group (n=73)

Combined group (n=83)

 

Baseline (mean (SD))

Follow-up (mean (SD))

Effect size (Cohen’s d)a

Baseline (mean (SD))

Follow-up (mean (SD))

Effect size (Cohen’s d)

Baseline (mean (SD))

Follow-up (mean (SD))

Effect size (Cohen’s d)

Importance of reducing prescribing

6.03b (1.27)

6.22 (1.00)

.15

5.85 (1.43)

6.34 (0.89)

.35**

5.90 (1.08)

6.25 (1.05)

.27*

Risks of reducing prescribing

4.37 (1.56)

4.88 (1.37)

.31*

4.81 (1.61)

5.16 (1.45)

.19

4.33 (1.47)

4.76 (1.50)

.23*

Risk to relationship with patients

4.49 (1.62)

4.63 (1.58)

.08

4.74 (1.80)

4.89 (1.61)

.08

4.76 (1.41)

5.12 (1.33)

.25*

Confidence to reduce prescribing

4.89 (1.49)

4.64 (1.49)

-.13

4.71 (1.79)

5.12 (1.70)

.21

4.86 (1.50)

5.28 (1.35)

.25*

  1. *p < .05, **p < .01 for change in mean score (paired samples t-test).
  2. aEffect size (d) reported such that positive value represents positive change.
  3. bScores are on a scale from 1 (disagree strongly) to 7 (agree strongly).